These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2208545)

  • 21. In vitro contracture tests for susceptibility to malignant hyperthermia.
    Rosenberg H; Reed S
    Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. W-7, a calmodulin antagonist, and contracture of malignant hyperthermia susceptible skeletal muscle.
    Holland M; Williams JH; Lee JC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Feb; 101(2):383-8. PubMed ID: 1354116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia.
    Gronert GA
    Anesth Analg; 1979; 58(5):367-71. PubMed ID: 573559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
    Foster PS; Hopkinson KC; Denborough MA
    Clin Exp Pharmacol Physiol; 1989 Oct; 16(10):799-805. PubMed ID: 2612062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.
    Nelson TE; Denborough MA
    Clin Exp Pharmacol Physiol; 1977; 4(3):315-22. PubMed ID: 891045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia in humans--standardization of contracture testing protocol.
    Melton AT; Martucci RW; Kien ND; Gronert GA
    Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro determination of susceptibility to malignant hyperthermia.
    Iaizzo PA; Lehmann-Horn F
    Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of midazolam on directly stimulated muscle biopsies from control and malignant hyperthermia positive patients.
    Fletcher JE; Rosenberg H; Hilf M
    Can Anaesth Soc J; 1984 Jul; 31(4):377-81. PubMed ID: 6146391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia.
    Gallant EM; Mickelson JR; Roggow BD; Donaldson SK; Louis CF; Rempel WE
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C781-6. PubMed ID: 2801926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of effects of several inhalation anaesthetics on caffeine-induced contractures of normal and malignant hyperthermic skeletal muscle.
    Britt BA; Endrenyi L; Frodis W; Scott E; Kalow W
    Can Anaesth Soc J; 1980 Jan; 27(1):12-5. PubMed ID: 7353185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures.
    Jaffe RS; Martucci RW; Gronert GA; Elliott TE; Cardinet GH
    Anesthesiology; 1991 Sep; 75(3):525-6. PubMed ID: 1888058
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of halothane on the Ca2+-transport system of surface membranes isolated from normal and malignant hyperthermia pig skeletal muscle.
    Rock E; Kozak-Reiss G
    Arch Biochem Biophys; 1987 Aug; 256(2):703-7. PubMed ID: 3039918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
    Lehmann-Horn F; Iaizzo PA
    Br J Anaesth; 1990 Nov; 65(5):692-7. PubMed ID: 2248848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
    Sullivan JS; Denborough MA
    Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of susceptibility to malignant hyperpyrexia in swine.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.